{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:55:41Z","timestamp":1784357741232,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573031"],"award-info":[{"award-number":["81573031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1618-8","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T12:26:27Z","timestamp":1528460787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus"],"prefix":"10.1186","volume":"20","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"1618_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","volume":"369","author":"DP D'Cruz","year":"2007","unstructured":"D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369:587\u201396.","journal-title":"Lancet"},{"key":"1618_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0092-8674(00)81108-3","volume":"85","author":"BL Kotzin","year":"1996","unstructured":"Kotzin BL. Systemic lupus erythematosus. Cell. 1996;85:303\u20136.","journal-title":"Cell"},{"key":"1618_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08916930903374741","volume":"43","author":"A Perl","year":"2010","unstructured":"Perl A. Pathogenic mechanisms in systemic lupus erythematosus. Autoimmunity. 2010;43:1\u20136.","journal-title":"Autoimmunity"},{"key":"1618_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.autrev.2008.07.047","volume":"8","author":"SA Jenks","year":"2009","unstructured":"Jenks SA, Sanz I. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev. 2009;8:209\u201313.","journal-title":"Autoimmun Rev"},{"key":"1618_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","volume":"6","author":"JC Crispin","year":"2010","unstructured":"Crispin JC, Kyttaris VC, Terhorst C, Tsokos GC. T cells as therapeutic targets in SLE. Nat Rev Rheumatol. 2010;6:317\u201325.","journal-title":"Nat Rev Rheumatol"},{"key":"1618_CR6","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"1618_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138.","journal-title":"Nature"},{"key":"1618_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"1618_CR9","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1038\/onc.2015.460","volume":"35","author":"W Yang","year":"2016","unstructured":"Yang W, Du WW, Li X, Yee AJ, Yang BB. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis. Oncogene. 2016;35:3919\u201331.","journal-title":"Oncogene"},{"key":"1618_CR10","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.18632\/oncotarget.3469","volume":"6","author":"F Li","year":"2015","unstructured":"Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt\/beta-catenin pathway. Oncotarget. 2015;6:6001\u201313.","journal-title":"Oncotarget"},{"key":"1618_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, Lyu D, Zheng B, Xu Y, Long Z, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319.","journal-title":"Cancer Lett"},{"key":"1618_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-017-0614-1","volume":"36","author":"R He","year":"2017","unstructured":"He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong W, Li X, Li G, Zeng Z, Tang H. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res. 2017;36:145.","journal-title":"J Exp Clin Cancer Res"},{"key":"1618_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-017-0719-3","volume":"16","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu H, Hou L, Wang G, Zhang R, Huang Y, Chen X, Zhu J. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16:151.","journal-title":"Mol Cancer"},{"key":"1618_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.autrev.2016.03.002","volume":"15","author":"H Wu","year":"2016","unstructured":"Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: aberrant DNA methylation. Autoimmun Rev. 2016;15:684\u20139.","journal-title":"Autoimmun Rev"},{"key":"1618_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2302\/kjm.60.10","volume":"60","author":"Y Renaudineau","year":"2011","unstructured":"Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011;60:10\u20136.","journal-title":"Keio J Med"},{"key":"1618_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","volume":"116","author":"MM Juntilla","year":"2008","unstructured":"Juntilla MM, Koretzky GA. Critical roles of the PI3K\/Akt signaling pathway in T cell development. Immunol Lett. 2008;116:104\u201310.","journal-title":"Immunol Lett"},{"key":"1618_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri2888","volume":"11","author":"D Finlay","year":"2011","unstructured":"Finlay D, Cantrell DA. Metabolism, migration and memory in cytotoxic T cells. Nat Rev Immunol. 2011;11:109\u201317.","journal-title":"Nat Rev Immunol"},{"key":"1618_CR18","doi-asserted-by":"publisher","first-page":"329098","DOI":"10.4061\/2011\/329098","volume":"2011","author":"A Bononi","year":"2011","unstructured":"Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, Giorgi C, Missiroli S, Poletti F, Rimessi A, et al. Protein kinases and phosphatases in the control of cell fate. Enzyme Res. 2011;2011:329098.","journal-title":"Enzyme Res"},{"key":"1618_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.immuni.2011.01.012","volume":"34","author":"AN Macintyre","year":"2011","unstructured":"Macintyre AN, Finlay D, Preston G, Sinclair LV, Waugh CM, Tamas P, Feijoo C, Okkenhaug K, Cantrell DA. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity. 2011;34:224\u201336.","journal-title":"Immunity"},{"key":"1618_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nm1291","volume":"11","author":"DF Barber","year":"2005","unstructured":"Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, Ruckle T, Schwarz MK, Rodriguez S, et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med. 2005;11:933\u20135.","journal-title":"Nat Med"},{"key":"1618_CR21","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.27505","volume":"62","author":"TE Taher","year":"2010","unstructured":"Taher TE, Parikh K, Flores-Borja F, Mletzko S, Isenberg DA, Peppelenbosch MP, Mageed RA. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 2010;62:2412\u201323.","journal-title":"Arthritis Rheum"},{"key":"1618_CR22","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.4161\/cc.8.17.9446","volume":"8","author":"H Tang","year":"2009","unstructured":"Tang H, Tan G, Guo Q, Pang R, Zeng F. Abnormal activation of the Akt-GSK3beta signaling pathway in peripheral blood T cells from patients with systemic lupus erythematosus. Cell Cycle. 2009;8:2789\u201393.","journal-title":"Cell Cycle"},{"key":"1618_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdermsci.2012.10.011","volume":"69","author":"H Qin","year":"2013","unstructured":"Qin H, Zhu X, Liang J, Wu J, Yang Y, Wang S, Shi W, Xu J. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J Dermatol Sci. 2013;69:61\u20137.","journal-title":"J Dermatol Sci"},{"key":"1618_CR24","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","volume":"113","author":"R Garzon","year":"2009","unstructured":"Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009;113:6411\u20138.","journal-title":"Blood"},{"key":"1618_CR25","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.18632\/oncotarget.675","volume":"3","author":"N Amodio","year":"2012","unstructured":"Amodio N, Leotta M, Bellizzi D, Di Martino MT, D'Aquila P, Lionetti M, Fabiani F, Leone E, Gulla AM, Passarino G, et al. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget. 2012;3:1246\u201358.","journal-title":"Oncotarget"},{"key":"1618_CR26","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","volume":"119","author":"LP Kil","year":"2012","unstructured":"Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, Thaiss F, Rimmelzwaan GF, Elewaut D, Delsing D, et al. Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood. 2012;119:3744\u201356.","journal-title":"Blood"},{"key":"1618_CR27","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/art.38047","volume":"65","author":"P Mina-Osorio","year":"2013","unstructured":"Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, et al. Suppression of glomerulonephritis in lupus-prone NZB x NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase. Arthritis Rheum. 2013;65:2380\u201391.","journal-title":"Arthritis Rheum"},{"key":"1618_CR28","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.4049\/jimmunol.1301553","volume":"191","author":"AL Rankin","year":"2013","unstructured":"Rankin AL, Seth N, Keegan S, Andreyeva T, Cook TA, Edmonds J, Mathialagan N, Benson MJ, Syed J, Zhan Y, et al. Selective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis. J Immunol. 2013;191:4540\u201350.","journal-title":"J Immunol"},{"key":"1618_CR29","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","volume":"107","author":"LA Honigberg","year":"2010","unstructured":"Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, Li S, Pan Z, Thamm DH, Miller RA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010;107:13075\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1618_CR30","doi-asserted-by":"crossref","unstructured":"Kong W, Deng W, Sun Y, Huang S, Zhang Z, Shi B, Chen W, Tang X, Yao G, Feng X, et al. Increased expression of Bruton's tyrosine kinase in peripheral blood is associated with lupus nephritis. Clin Rheumatol. 2018;37(1):43\u201349.","DOI":"10.1007\/s10067-017-3717-3"},{"key":"1618_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/ni1001-939","volume":"2","author":"W Liu","year":"2001","unstructured":"Liu W, Quinto I, Chen X, Palmieri C, Rabin RL, Schwartz OM, Nelson DL, Scala G. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein. Nat Immunol. 2001;2:939\u201346.","journal-title":"Nat Immunol"},{"key":"1618_CR32","first-page":"246ra299","volume":"6","author":"XN Wu","year":"2014","unstructured":"Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, Chen H, Zhao LD, Zeng XF, Zhang FC, et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med. 2014;6:246ra299.","journal-title":"Sci Transl Med"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1618-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1618-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T07:21:55Z","timestamp":1604388115000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1618-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1618-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"28 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the Institutional Research Ethics Committee of Shanghai General Hospital and abided by the ethical guidelines of the Declaration of Helsinki. Informed consent was obtained from all the patients involved in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"118"}}